Viveve Medical, Inc. (VIVE)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0001 (-33.33%)
Feb 9, 2026, 11:36 AM EST

Viveve Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2021FY 2020FY 2019FY 2018FY 2017
Period Ending
Sep '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Net Income
-22.99-22.03-21.92-42.53-49.98-36.96
Depreciation & Amortization
0.811.141.31.180.790.45
Loss (Gain) From Sale of Assets
0.090.110.020.11--
Stock-Based Compensation
3.753.782.652.43.292.13
Provision & Write-off of Bad Debts
0.030.130.451.030.18-0.22
Other Operating Activities
0.66-0.382.378.281.581.05
Change in Accounts Receivable
-0.380.10.353.10.33-3.9
Change in Inventory
0.92.211.36-1.07-1.99-0.07
Change in Accounts Payable
-0.180.6-0.73-2.39-0.811.71
Change in Other Net Operating Assets
0.431.21-1.48-1.982.860.95
Operating Cash Flow
-16.23-12.88-15.23-31.24-43.09-34.85
Capital Expenditures
-0.6-0.46-0.78-1.09-2.14-0.91
Investment in Securities
------2.5
Investing Cash Flow
-0.6-0.46-0.78-1.09-2.14-3.41
Long-Term Debt Issued
--1.34--29.21
Total Debt Issued
--1.34--29.21
Long-Term Debt Repaid
------10
Total Debt Repaid
------10
Net Debt Issued (Repaid)
--1.34--19.21
Issuance of Common Stock
0.0726.048.7518.3258.1534.93
Repurchase of Common Stock
----0.01--
Other Financing Activities
0-0.07-0.86-2.2-4.13-3.24
Financing Cash Flow
0.0725.979.2316.1154.0350.9
Net Cash Flow
-16.7612.64-6.79-16.228.7912.64
Free Cash Flow
-16.83-13.33-16.02-32.32-45.23-35.76
Free Cash Flow Margin
-246.51%-207.50%-292.30%-492.20%-244.27%-233.90%
Free Cash Flow Per Share
-1.58-1.32-10.18-259.03-1456.33-2043.66
Cash Interest Paid
---2.512.672.07
Cash Income Tax Paid
----0-
Levered Free Cash Flow
-7.57-6.51-8.01-20.16-28.58-22.75
Unlevered Free Cash Flow
-6.88-5.89-7.44-17.44-25.85-20.77
Change in Working Capital
0.774.12-0.5-2.340.4-1.3
Source: S&P Global Market Intelligence. Standard template. Financial Sources.